Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CRP Exemption Timeframes, Confidentiality Safeguards Addressed By CHPA

This article was originally published in The Tan Sheet

Executive Summary

OTC drug companies need substantial preparation time as well as ensured confidentiality when submitting child-resistant packaging exemption requests, CHPA stresses in recent comments to the Consumer Product Safety Commission.

You may also be interested in...



CPSC Rx-To-OTC Switch Final Rule Published As Gall Loses Chair Nomination

Manufacturers cannot be ensured confidentiality when submitting child-resistant packaging (CRP) exemption requests for oral Rx-to-OTC switches, the Consumer Product Safety Commission clarifies in its final rule requiring CRP for all such drugs.

CPSC Rx-To-OTC Switch Final Rule Published As Gall Loses Chair Nomination

Manufacturers cannot be ensured confidentiality when submitting child-resistant packaging (CRP) exemption requests for oral Rx-to-OTC switches, the Consumer Product Safety Commission clarifies in its final rule requiring CRP for all such drugs.

CPSC Rx-To-OTC Switch Final Rule Published As Gall Loses Chair Nomination

Manufacturers cannot be ensured confidentiality when submitting child-resistant packaging (CRP) exemption requests for oral Rx-to-OTC switches, the Consumer Product Safety Commission clarifies in its final rule requiring CRP for all such drugs.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091927

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel